Pyrotinib as neoadjuvant therapy for HER2+breast cancer: A multicenter, randomized, controlled, phase II trial.
文献类型：期刊论文
| 作者 | Ding, Xiaowen; Mo, Wenju; Xie, Xiaohong; Wang, Ouchen; Ding, Yuqin; Zhao, Shuai; He, Xiangming; Feng, Weiliang; Zou, Dehong; Yang, Hongjian |
| 刊名 | JOURNAL OF CLINICAL ONCOLOGY
 |
| 出版日期 | 2021-05-20 |
| 卷号 | 39 |
| ISSN号 | 0732-183X |
| DOI | 10.1200/JCO.2021.39.15_suppl.574 |
| 资助项目 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. |
| WOS研究方向 | Oncology |
| 语种 | 英语 |
| WOS记录号 | WOS:000708120600084 |
| 出版者 | LIPPINCOTT WILLIAMS & WILKINS |
| 资助机构 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. |
| 源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/126494]  |
| 专题 | 中国科学院合肥物质科学研究院 |
| 作者单位 | 1.Univ Chinese Acad Sci, Chinese Acad Sci, Inst Canc & Basic Med ICBM, Canc Hosp,Zhejiang Canc Hosp, Hangzhou, Peoples R China 2.Zhejiang Hosp Tradit Chinese Med, Hangzhou, Peoples R China 3.Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Peoples R China |
| 推荐引用方式 GB/T 7714 | Ding, Xiaowen,Mo, Wenju,Xie, Xiaohong,et al. Pyrotinib as neoadjuvant therapy for HER2+breast cancer: A multicenter, randomized, controlled, phase II trial.[J]. JOURNAL OF CLINICAL ONCOLOGY,2021,39. |
| APA | Ding, Xiaowen.,Mo, Wenju.,Xie, Xiaohong.,Wang, Ouchen.,Ding, Yuqin.,...&Yang, Hongjian.(2021).Pyrotinib as neoadjuvant therapy for HER2+breast cancer: A multicenter, randomized, controlled, phase II trial..JOURNAL OF CLINICAL ONCOLOGY,39. |
| MLA | Ding, Xiaowen,et al."Pyrotinib as neoadjuvant therapy for HER2+breast cancer: A multicenter, randomized, controlled, phase II trial.".JOURNAL OF CLINICAL ONCOLOGY 39(2021). |
入库方式： OAI收割
来源：合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。